IBM Shares Slide 13% on AI Modernization Concerns

The Motley FoolThe Motley Fool
|||2 min read
Key Takeaway

IBM shares fell 13% as AI tools threaten its legacy modernization business, which represents 23% of revenue. Investors worry about automation disrupting this critical earnings stream.

IBM Shares Slide 13% on AI Modernization Concerns

IBM's stock declined sharply on Monday, erasing approximately $31 billion in market capitalization as investors reassessed risks to the company's legacy systems business. The sell-off was triggered by concerns that artificial intelligence tools developed by Anthropic could accelerate the automation of COBOL code modernization—a critical revenue stream for IBM's enterprise services division. The mainframe modernization segment represents roughly 23% of IBM's total revenue, making investor concerns regarding potential disruption material to the company's financial outlook.

The stock has declined 22% year-to-date, reflecting broader market skepticism about IBM's competitive positioning in the AI era. IBM management has sought to mitigate investor concerns by positioning code translation as merely one component of a comprehensive modernization strategy that encompasses infrastructure, architecture redesign, and organizational transformation. However, the market's reaction underscores heightened sensitivity among technology investors regarding how legacy-focused companies will adapt to rapid artificial intelligence adoption.

The selloff presents a valuation inflection point for investors to evaluate IBM's long-term strategic positioning. Key considerations include the timeline and magnitude of potential revenue displacement in the modernization services segment, the company's ability to develop competing AI-driven solutions, and the resilience of higher-margin consulting services against automation threats. IBM's dividend yield and near-term financial metrics remain intact, though investors should monitor upcoming earnings guidance and strategic commentary for clarity on management's response to accelerating AI capabilities.

Source: The Motley Fool

Back to newsPublished Feb 24

Related Coverage

GlobeNewswire Inc.

Tech Interactive Launches Nation's Largest AI Literacy Event, Drawing 1,000+ Students

The Tech Interactive hosts record-breaking National AI Literacy Day on March 27, engaging over 1,000 K-12 students with hands-on AI learning and industry leaders.

GOOGGOOGLIBM
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
Investing.com

D-Wave's 44% Plunge Masks Quantum Leap: Growth Story vs. Valuation Reality

D-Wave ($QBTS) fell 44% in 2026 despite strong bookings exceeding 2025 totals and $30M in major deals. Analysts see 132% upside, but 237x sales valuation remains extreme.

QBTS
GlobeNewswire Inc.

OneMain Holdings Faces Multi-State Securities Probe Over Alleged Lending Fraud

Pomerantz Law Firm investigates $OMF following multi-state lawsuit alleging deceptive lending practices. Stock tumbles 5.38% on fraud allegations.

OMF
GlobeNewswire Inc.

Boston Scientific Faces Securities Fraud Lawsuit Over Overstated EP Growth Claims

Boston Scientific faces class action lawsuit alleging material misstatements about electrophysiology growth. Stock fell 17.6% after disclosing slower market growth and competitive pressures.

BSX
GlobeNewswire Inc.

Nektar Therapeutics Faces Class Action Over Failed Trial Data Disclosure

Pomerantz LLP filed securities fraud class action against Nektar Therapeutics, alleging false statements about clinical trial enrollment procedures led to trial failure and stock decline.

NKTR